Skye Bioscience (SKYE) EPS (Basic) (2012 - 2026)
Skye Bioscience (SKYE) posted quarterly EPS (Basic) of -$0.32 for Q1 2026, down 12.58% year-over-year from -$0.36 in Q1 2025, and up 13.42% quarter-over-quarter from -$0.36 in Q4 2025.
Skye Bioscience (SKYE) EPS (Basic) (2012 - 2026) Analysis & Trends
Skye Bioscience (SKYE) has reported EPS (Basic) for 15 consecutive years, with -$0.32 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 12.58% year-over-year to -$0.32; the TTM figure through Mar 2026 stood at -$1.44 (down 75.46% YoY), while the FY2025 annual figure was -$1.41, down 93.65% from the prior year.
- EPS (Basic) grew to -$0.32 in Q1 2026 per SKYE's latest filing, from -$0.36 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.1 in Q3 2024 and bottomed at -$4.45 in Q4 2022.
- Historically, EPS (Basic) has averaged -$1.04 across 5 years, with a median of -$0.44 in 2025.
- Annual changes were most pronounced in 2024 — EPS (Basic) soared 96.83% — and 2025, when it slumped 220.2%.
- Skye Bioscience's EPS (Basic) stood at -$4.45 in 2022, then surged by 85.83% to -$0.63 in 2023, then soared by 57.66% to -$0.27 in 2024, then slumped by 36.31% to -$0.36 in 2025, then rose by 13.42% to -$0.32 in 2026.
- Business Quant data shows SKYE's EPS (Basic) at -$0.32 in Q1 2026, -$0.36 in Q4 2025, and -$0.32 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.18 |
| 10 | Skye Bioscience | 10.71 Mn | 10.71 Mn | - | -0.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.32 |
| Dec 31, 2025 | -0.36 |
| Sep 30, 2025 | -0.32 |
| Jun 30, 2025 | -0.44 |
| Mar 31, 2025 | -0.28 |
| Dec 31, 2024 | -0.27 |
| Sep 30, 2024 | -0.10 |
| Jun 30, 2024 | -0.20 |
| Mar 31, 2024 | -0.18 |
| Dec 31, 2023 | -0.63 |
| Sep 30, 2023 | -3.17 |
| Jun 30, 2023 | -0.80 |
| Mar 31, 2023 | -1.37 |
| Dec 31, 2022 | -4.45 |
| Sep 30, 2022 | -1.58 |
| Jun 30, 2022 | -1.72 |
| Mar 31, 2022 | -1.53 |
| Dec 31, 2021 | -1.55 |
| Sep 30, 2021 | -1.10 |
| Jun 30, 2021 | -1.34 |